Aimm Therapeutics' Unattributed VC Round

Aimm Therapeutics raised a round of funding on June 05, 2009. Investors include Life Sciences Fund Amsterdam.

AIMM is a biotech company spun-out of the Netherlands Cancer Institute and the Academic Medical Center at the University of Amsterdam. The company aims to develop high quality human monoclonal antibod…

Articles about Aimm Therapeutics' Unattributed VC Round: